The ISSCR addresses access and affordability in cell and gene therapies; convenes summit on 20 March 2026
Meeting Announcement
Updates every hour. Last Updated: 27-Jan-2026 23:11 ET (28-Jan-2026 04:11 GMT/UTC)
Bringing the promise of cell and gene therapies to patients is one of the greatest defining opportunities in, and responsibilities of, modern medicine. To that end, The International Society for Stem Cell Research (ISSCR), in collaboration with the California Institute for Regenerative Medicine (CIRM) and the UCLA Broad Stem Cell Research Center, will host the Summit on Access and Affordability in Cell and Gene Therapies on 20 March 2026.
The summit convenes global leaders to confront scientific, economic, and systematic barriers that may limit patient access to potentially curative cellular medicines. Experts in research, clinical care, policy, market access, economics and patient advocacy will engage in cross-sector dialogue to explore pricing, manufacturing, regulation, and reimbursement strategies.